| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001058946A3 Polynucleotides and polypeptides encoded thereby |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001058240A3 Photodynamic therapy for treating conditions of the eye |
| 04/11/2002 | WO2001057209A3 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 04/11/2002 | WO2001055320A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001055316A3 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | WO2001053835A3 Methods for detecting cancer of the central nervous system |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001051673A8 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 04/11/2002 | WO2001051511A3 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 04/11/2002 | WO2001051011A3 Condensation products of proteins, whereby azelaic acid is used |
| 04/11/2002 | WO2001039573A3 Novel use of lung surfactant for treating legionnaire's disease |
| 04/11/2002 | WO2001024782A3 Pharmaceutical agent for the treatment of cachexia and/or cardiogenic shock |
| 04/11/2002 | WO2000063689A9 Detecting and suppressing malignancy based on expression of spleen tyrosine kinase (syk) |
| 04/11/2002 | WO2000058523A9 Glucocorticoid receptor agonist and decreased pp5 |
| 04/11/2002 | WO2000052167A9 Angiopoietin-related protein and nucleic acids |
| 04/11/2002 | WO2000052048A9 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 04/11/2002 | WO2000047214A9 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts |
| 04/11/2002 | WO2000038518A9 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | WO2000032774A9 12216 receptor, a g-protein coupled receptor |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042812 Apparatus, method and system for voice over a network having provider selection and disputeless billing |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042445 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 04/11/2002 | US20020042419 Administering growth hormone secretagogue |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042408 Antibiotic compounds |
| 04/11/2002 | US20020042396 Amino acid derivatives |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042384 Integrin-targeting vectors having transfection activity |
| 04/11/2002 | US20020042382 Sequestrin |
| 04/11/2002 | US20020042381 Antilipemic agents |
| 04/11/2002 | US20020042378 Drug delivery; biocompatible polymer |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042375 Method of treating cancer |
| 04/11/2002 | US20020042374 Method of treating insulin insensitivity and syndrome x |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042370 Method of treating graft rejection using inhibitors of CCR2 function |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042366 Method for treating inflammation |
| 04/11/2002 | US20020042365 Vancomycin analogs |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042363 Nonantigenic stabilizer and physiologically active substance |
| 04/11/2002 | US20020042360 Antitumor agents |
| 04/11/2002 | US20020042358 Sphingosine kinase, cloning, expression and methods of use |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042126 Polypeptide for use in the diagnosis, prevention and treatment of cancer, immunological and nervous system disorders |
| 04/11/2002 | US20020042119 Novel Metalloproteinases |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042102 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042100 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 04/11/2002 | US20020042099 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 04/11/2002 | US20020042098 32253 transferase family members and uses therefor |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020042084 Enzymatic reaction of a substrate radiolabelled at the C-terminal glutamate group detected by its binding to fluomicrospheres |
| 04/11/2002 | US20020042066 Polypeptide for use in diagnosis, prevention, and treatment of tissue damage and cancer |
| 04/11/2002 | US20020042064 p53 binding areas |
| 04/11/2002 | US20020042062 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| 04/11/2002 | US20020042057 Nucleotide sequences for use in the treatment of cardiomyopathies |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020041976 Novel compounds and their manufacture and use |
| 04/11/2002 | US20020041900 Chondrocyte cultures and fractions therefrom |
| 04/11/2002 | US20020041898 Novel targeted delivery systems for bioactive agents |
| 04/11/2002 | US20020041893 Biodegradable polymer and drug complex; sustained release |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | US20020041881 Identification and characterization of novel pneumococcal choline binding protein, cbpg, and diagnostic and therapeutic uses thereof |
| 04/11/2002 | US20020041880 Mixture of angiogenesis inhibitor and prostate specific antigen |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041874 Administering integrin antagonist |
| 04/11/2002 | US20020041873 Administering neutrotrophic factor inhibitor |
| 04/11/2002 | US20020041871 Phytase and enzyme |
| 04/11/2002 | US20020041870 Novel genes expressed in obese rat hypothalamus |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041868 Cell fusions and methods of making and using the same |
| 04/11/2002 | US20020041863 Preventive and/or therapeutic agent for cachexia |
| 04/11/2002 | DE10049937A1 New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis |
| 04/11/2002 | DE10048950A1 Activating p53-responsive promoter, useful for treating tumors that contain mutant forms of p53, using an adaptor protein that links the promoter to mutated p53 |
| 04/11/2002 | DE10048840A1 Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren Use of lipopeptides or lipoproteins in the treatment of lung infections and tumors |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2448483A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 04/11/2002 | CA2426621A1 Drug resistance-associated gene and use thereof |
| 04/11/2002 | CA2425906A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | CA2425789A1 Perilipin as a target for regulation of body weight, muscle mass and diabetes |
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |